Daiichi Sankyo Company, Limited (DSNKY)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 03:59PM EDT
| Previous close | 35.86 |
| Open | 37.18 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 35.77 - 37.18 |
| 52-week range | 23.72 - 37.57 |
| Volume | |
| Avg. volume | 181,030 |
| Market cap | 69.356B |
| Beta (5Y monthly) | 0.29 |
| PE ratio (TTM) | 53.19 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.24 (0.68%) |
| Ex-dividend date | 28 Sept 2023 |
| 1y target est | N/A |
- Yahoo Finance
AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain'
AstraZeneca CEO Pascal Soriot joined Yahoo Finance to discuss the company's earnings today.
- Zacks
Atossa (ATOS) Reports Positive Results From EVANGELINE Study
Atossa (ATOS) unveils positive results from its phase 2 EVANGELINE clinical study, which shows that (Z)-endoxifen can reduce the growth of ER+ breast cancer.
- Zacks
Merck (MRK) Begins Phase II/II Ovarian Cancer Study on ADC Drug (Revised)
Merck's (MRK) phase II/III study called REJOICE-Ovarian01 study will evaluate the efficacy of raludotatug deruxtecan in patients with platinum-resistant ovarian cancer.
© 2024 Yahoo. All rights reserved.